These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 33689775

  • 1. Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC).
    Yan Y, Zheng L, Du Q, Yazdani H, Dong K, Guo Y, Geller DA.
    Cancer Lett; 2021 May 28; 506():95-106. PubMed ID: 33689775
    [Abstract] [Full Text] [Related]

  • 2. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
    Wei Y, Lao XM, Xiao X, Wang XY, Wu ZJ, Zeng QH, Wu CY, Wu RQ, Chen ZX, Zheng L, Li B, Kuang DM.
    Gastroenterology; 2019 May 28; 156(6):1890-1904.e16. PubMed ID: 30711627
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8+- T cell-mediated anti-tumor immunity.
    Xin X, Li Z, Yan X, Liu T, Li Z, Chen Z, Yan X, Zeng F, Hou L, Zhang J.
    Theranostics; 2024 May 28; 14(15):5853-5868. PubMed ID: 39346534
    [Abstract] [Full Text] [Related]

  • 5. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
    Nishina S, Yamauchi A, Kawaguchi T, Kaku K, Goto M, Sasaki K, Hara Y, Tomiyama Y, Kuribayashi F, Torimura T, Hino K.
    Cell Mol Gastroenterol Hepatol; 2019 May 28; 7(1):115-134. PubMed ID: 30510994
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells.
    Yan Y, Zheng L, Du Q, Yan B, Geller DA.
    Cancer Immunol Immunother; 2020 Sep 28; 69(9):1891-1903. PubMed ID: 32377817
    [Abstract] [Full Text] [Related]

  • 9. Chemokine (C-X-C motif) receptor 3-positive B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma.
    Liu RX, Wei Y, Zeng QH, Chan KW, Xiao X, Zhao XY, Chen MM, Ouyang FZ, Chen DP, Zheng L, Lao XM, Kuang DM.
    Hepatology; 2015 Dec 28; 62(6):1779-90. PubMed ID: 26235097
    [Abstract] [Full Text] [Related]

  • 10. Hepatocellular carcinoma and CXCR3 chemokines: a narrative review.
    Elia G, Fallahi P.
    Clin Ter; 2017 Dec 28; 168(1):e37-e41. PubMed ID: 28240761
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands.
    Wendel M, Galani IE, Suri-Payer E, Cerwenka A.
    Cancer Res; 2008 Oct 15; 68(20):8437-45. PubMed ID: 18922917
    [Abstract] [Full Text] [Related]

  • 13. Radiofrequency ablation-increased CXCL10 is associated with earlier recurrence of hepatocellular carcinoma by promoting stemness.
    Ouyang Y, Liu K, Hao M, Zheng R, Zhang C, Wu Y, Zhang X, Li N, Zheng J, Chen D.
    Tumour Biol; 2016 Mar 15; 37(3):3697-704. PubMed ID: 26462839
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatic Symbiotic Bacterium L. reuteri FLRE5K1 Inhibits the Development and Progression of Hepatocellular Carcinoma via Activating the IFN-γ/CXCL10/CXCR3 Pathway.
    Zhang N, Ye S, Wang X, Wang K, Zhong F, Yao F, Liu J, Huang B, Xu F, Wang X.
    Probiotics Antimicrob Proteins; 2024 Aug 15; 16(4):1158-1171. PubMed ID: 37289406
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse.
    Kim J, Choi JY, Park SH, Yang SH, Park JA, Shin K, Lee EY, Kawachi H, Kohsaka H, Song YW.
    Arthritis Res Ther; 2014 Jun 17; 16(3):R126. PubMed ID: 24939012
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Icaritin inhibited cigarette smoke extract-induced CD8+ T cell chemotaxis enhancement by targeting the CXCL10/CXCR3 axis and TGF-β/Smad2 signaling.
    Li Q, Sun J, Cao Y, Liu B, Zhao Z, Hu L, Zhang H, Kong Q, Wu J, Dong J.
    Phytomedicine; 2022 Feb 17; 96():153907. PubMed ID: 35026517
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.